You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Koninklijke Philips N.V. (PHG) - free report >>
OptimizeRx Corp. (OPRX) - free report >>
ADMA Biologics Inc (ADMA) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 11th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
ADMA Biologics, Inc. (ADMA - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA Biologics Inc Price and Consensus
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
Arcutis Biotherapeutics, Inc. (ARQT - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Arcutis Biotherapeutics, Inc. Price and Consensus
Arcutis Biotherapeutics, Inc. price-consensus-chart | Arcutis Biotherapeutics, Inc. Quote
Phreesia, Inc. (PHR - Free Report) : This company that provides a SaaS-based software and payment platform for the healthcare industry has seen the Zacks Consensus Estimate for its current year earnings increasing 11.1% over the last 60 days.
Phreesia, Inc. Price and Consensus
Phreesia, Inc. price-consensus-chart | Phreesia, Inc. Quote
OptimizeRx Corporation (OPRX - Free Report) : This digital health technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.
OptimizeRx Corp. Price and Consensus
OptimizeRx Corp. price-consensus-chart | OptimizeRx Corp. Quote
Koninklijke Philips N.V. (PHG - Free Report) : This health technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
Koninklijke Philips N.V. Price and Consensus
Koninklijke Philips N.V. price-consensus-chart | Koninklijke Philips N.V. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.